Tennis Elbow Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Tennis Elbow Treatment Market is Segmented by Treatment Type (Surgical Therapies, Non-surgical Therapies) and Geography.

Market Snapshot

Tennis Elbow Treatment Market Overview
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.1 %
Tennis Elbow Treatment Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The tennis elbow treatment market was anticipated to record a CAGR of nearly 4.1% during the forecast period. The growing burden of lateral epicondylitis, increase in target population, and launch of cost-effective treatment options are the major growth propellers for the market. A rising number of sports-related injuries is also anticipated to drive the growth. As per the Stanford Children’s Health, each year around 3.5 million children ages 14 and below are affected by some form of sport-related injuries. The aforementioned factors are likely to drive the demand for tennis elbow treatment.

Increase in the geriatric population base also contributes to the prevalence of lateral epicondylitis. The target disease is found to be more prevalent in the geriatric population. With an upsurge in lifestyle disorders, the market is anticipated to register significant growth in near future. Moreover, favorable government initiatives such as Integrated Care for Older People to raise the awareness about geriatric health drives the demand for the market.

In addition, increasing efforts undertaken by major companies for the development of technological advanced products will also support market growth. Involvement of international organizations serves as a catalyst in the tennis elbow treatment market.

However, sluggish commercialization of new effective therapies may hamper business growth in the future.

Scope of the Report

As per the scope of the report, tennis elbow (lateral epicondylitis) is a painful condition caused by the repetitive motion of arms and elbow. A kind of tendinitis, the condition involves swelling of tendons and is identified on medical examination. Lateral epicondylitis (tennis elbow) is an inflammatory condition observed usually in tennis players, baseball players, swimmers, carpenters, plumbers, and anyone who repeats an arm motion over and over. The tennis elbow treatment market is segmented by treatment type and geography.

By Treatment Type
Surgical Therapies
Arthroscopic Surgery
Open Surgery
Non-surgical Therapies
Extracorporeal Shock Wave Therapy
Physical Therapies
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Braces by Non-surgical Therapies Segment is Expected To Showcase Significant Growth Over The Forecast Period.

  • Braces segment is expected to exhibit lucrative growth over the forecast period owing to the increasing incidence of sports injuries and growing getraitric population. The braces are mostly recommended after ACL injury and for decreasing any additional injury post ACL reconstruction. As per the centers for Disease Control and Prevention, anterior cruciate ligament (ACL) injury affects around 250,000 individuals in the United States annually, resulting in an annual health care cost exceeding USD 2 billion. Increasing incidence of pneumocccal disease is a high impact rendering driver. It will eventually increase the market for braces.
  • Technological advancements in knee braces over the years are also projected to bolster the market growth. For instance, spring loaded technology launched Levitation 2, a bionic brace which is reported to reduce the knee joint load by up to 64%.
  • Furthermore, favorable reimbursement scenario bode a well for brace segment. Agencies, such as the Centers for Medicare and Medicaid, offer up to 80% reimbursement for knee braces. The aforementioned factors are driving the demand for the product.
Tennis Elbow Treatment Market Key Trends

The North America Dominates the Market and is Expected to Continue the Same during the Forecast Period

North America dominated the tennis elbow treatment market in terms of revenue share in 2019. Increasing number of sport events and competitions in the United States coupled with increasing patient awareness level are the vital factors for the growth of tennis elbow treatment market in this region. Furthermore, factors such as rising geriatric population, and availability of insurance coverage are projected to drive the regional demand. The US Department of Health and Human Services’ National Youth Sports Strategy for increasing awareness of the benefits of participation in sports and regular physical activity, as well as the importance of good nutrition is boosting the regional growth for the market.

Asia-Pacific is expected to showcase lucrative growth over the forecast period. The growth can be attributed to an increased number of medical tourism and government initiatives. Moreover, the rising aging population at the risk of tennis elbow and other joint problems is expected to drive the regional product demand. Rising medical tourism in Asia-Pacific due to cheaper procedural costs is further propelling the market growth.

Tennis Elbow Treatment Market Growth Rate

Competitive Landscape

The tennis elbow treatment market is consolidated in nature. Various companies are striving to gain market share by adopting competitive strategies, such as joint ventures and research partnerships. Some key players operating in the market include Teikoku Pharma USA Inc., DJO Global Inc., Zimmer Biomet, 3M, and AKSIGEN.

The players are constantly involved in strategic initiatives, such as new product launch, technological advancements, regional expansion, and mergers and acquisitions in order to gain deeper penetration. For instance, Zimmer Biomet's, Tether treatment of scoliosis, providing a fusion-less alternative for young patients requiring surgery for young patients with scoliosis receives FDA approval.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Cases of Lateral Epicondylitis and Sport-related Injuries

      2. 4.2.2 Increase in Target Population Base

      3. 4.2.3 Technological Advancement and favorable Reimbursement

    3. 4.3 Market Restraints

      1. 4.3.1 Sluggish Commercialization of New Effective Therapies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Treatment Type

      1. 5.1.1 Surgical Therapies

        1. Arthroscopic Surgery

        2. Open Surgery

      2. 5.1.2 Non-surgical Therapies

        1. Extracorporeal Shock Wave Therapy

        2. Braces

        3. Medications

        4. Physical Therapies

    2. 5.2 Geography

      1. 5.2.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.2.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.2.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.2.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 3M

      2. 6.1.2 AKSIGEN

      3. 6.1.3 BTL

      4. 6.1.4 DJO Global Inc.

      5. 6.1.5 Johari Digital

      6. 6.1.6 Ossur Corporate

      7. 6.1.7 OttoBock HealthCare

      8. 6.1.8 Teikoku Pharma USA Inc.

      9. 6.1.9 Veritas Health LLC

      10. 6.1.10 Zimmer Biomet

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Tennis Elbow Treatment Market market is studied from 2018 - 2026.

The Tennis Elbow Treatment Market is growing at a CAGR of 4.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

DJO Global, Inc. , Teikoku Pharma USA, Inc, Zimmer Biomet , 3M, AKSIGEN are the major companies operating in Tennis Elbow Treatment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!